Filing Details
- Accession Number:
- 0001104659-13-062401
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-08-09 17:02:28
- Reporting Period:
- 2013-08-08
- Filing Date:
- 2013-08-09
- Accepted Time:
- 2013-08-09 17:02:28
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1232524 | Jazz Pharmaceuticals Plc | JAZZ | Pharmaceutical Preparations (2834) | 981032470 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1397661 | W Kenneth O'keefe | C/O Beecken Petty O' Keefe &Amp; Company 131 Dearborn St., Suite 2800 Chicago IL 60603 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2013-08-08 | 2,250 | $0.00 | 4,500 | No | 4 | A | Direct | |
| Ordinary Shares | Disposition | 2013-08-08 | 261,212 | $81.32 | 0 | No | 4 | S | Indirect | By Fund II and Fund II GP (as defined in footnote 2) |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | A | Direct | |
| No | 4 | S | Indirect | By Fund II and Fund II GP (as defined in footnote 2) |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Nonstatutory Stock Option (right to buy) | Acquisiton | 2013-08-08 | 4,500 | $0.00 | 4,500 | $81.76 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 4,500 | 2023-08-07 | No | 4 | A | Direct |
Footnotes
- These restricted stock units are granted pursuant to the Issuer's 2007 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on August 1, 2014. Upon vesting of the units and delivery of shares, such ordinary shares will be held for the benefit of Beecken Petty O'Keefe & Company II, L.P.
- Beecken Petty O'Keefe Fund II, L.P., Beecken Petty O'Keefe QP Fund II, L.P. and Beecken Petty O'Keefe Executive Fund II, L.P., as tenants in common (collectively, "Fund II") and Beecken Petty O'Keefe & Company II, L.P. (the "Fund II GP") were the holders. The Fund II GP is the general partner of Fund II and Beecken Petty O'Keefe & Company, LLC is the general partner of the Fund II GP. The Reporting Person is a partner at Beecken Petty O'Keefe & Company, LLC and shared voting and investment power over the shares sold by Fund II and the Fund II GP. The Reporting Person disclaims beneficial ownership of the shares sold by Fund II and the Fund II GP except to the extent of his proportionate pecuniary interest therein.
- This option is granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vests in 12 equal monthly installments beginning on September 1, 2013. Upon exercise of this option for shares, such ordinary shares will be held for the benefit of Beecken Petty O'Keefe & Company II, L.P.
Billionaire Hedge Funds
